Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Magnetic Resonance Imaging | 23 | 2025 | 3593 | 1.540 |
Why?
|
| Hydrocephalus | 3 | 2024 | 277 | 0.970 |
Why?
|
| Arnold-Chiari Malformation | 2 | 2024 | 47 | 0.920 |
Why?
|
| Skull Base Neoplasms | 1 | 2022 | 31 | 0.770 |
Why?
|
| Neural Tube Defects | 1 | 2024 | 362 | 0.660 |
Why?
|
| Pons | 2 | 2024 | 33 | 0.570 |
Why?
|
| Leukoencephalopathies | 2 | 2018 | 60 | 0.550 |
Why?
|
| Neuroimaging | 8 | 2025 | 352 | 0.550 |
Why?
|
| Contrast Media | 6 | 2022 | 450 | 0.520 |
Why?
|
| Societies, Medical | 6 | 2022 | 724 | 0.480 |
Why?
|
| Child | 31 | 2025 | 25112 | 0.430 |
Why?
|
| White Matter | 2 | 2025 | 205 | 0.430 |
Why?
|
| Neck Injuries | 1 | 2014 | 23 | 0.420 |
Why?
|
| Angiography | 1 | 2014 | 184 | 0.410 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 79 | 0.410 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 591 | 0.390 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2015 | 360 | 0.380 |
Why?
|
| Brain Stem | 2 | 2022 | 109 | 0.380 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2014 | 202 | 0.370 |
Why?
|
| Brain | 6 | 2025 | 3031 | 0.370 |
Why?
|
| Vestibular Nerve | 1 | 2011 | 3 | 0.360 |
Why?
|
| Nervous System Malformations | 1 | 2011 | 119 | 0.320 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2011 | 154 | 0.310 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2022 | 2012 | 0.310 |
Why?
|
| Brain Injuries | 2 | 2025 | 692 | 0.300 |
Why?
|
| Diagnosis, Differential | 9 | 2025 | 1823 | 0.300 |
Why?
|
| Humans | 47 | 2025 | 126134 | 0.300 |
Why?
|
| Evidence-Based Medicine | 6 | 2022 | 604 | 0.290 |
Why?
|
| Craniocerebral Trauma | 2 | 2020 | 136 | 0.290 |
Why?
|
| Sinusitis | 2 | 2020 | 117 | 0.280 |
Why?
|
| Infant | 14 | 2025 | 12803 | 0.280 |
Why?
|
| Epilepsy | 1 | 2015 | 846 | 0.280 |
Why?
|
| Inflammation | 1 | 2015 | 1434 | 0.270 |
Why?
|
| Retrospective Studies | 15 | 2025 | 16831 | 0.260 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2015 | 1121 | 0.240 |
Why?
|
| Child, Preschool | 15 | 2025 | 14375 | 0.240 |
Why?
|
| Pediatrics | 1 | 2015 | 1205 | 0.240 |
Why?
|
| Demyelinating Diseases | 2 | 2018 | 65 | 0.240 |
Why?
|
| Near Drowning | 1 | 2025 | 29 | 0.230 |
Why?
|
| Brain Neoplasms | 3 | 2022 | 1218 | 0.230 |
Why?
|
| Seizures | 3 | 2025 | 853 | 0.230 |
Why?
|
| Cranial Nerves | 1 | 2024 | 18 | 0.220 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2025 | 77 | 0.220 |
Why?
|
| Skull | 2 | 2022 | 147 | 0.220 |
Why?
|
| Skull Base | 1 | 2024 | 46 | 0.210 |
Why?
|
| Tuberculosis, Spinal | 1 | 2023 | 9 | 0.210 |
Why?
|
| Tuberculosis, Central Nervous System | 1 | 2023 | 11 | 0.210 |
Why?
|
| Actinomycetaceae | 1 | 2023 | 6 | 0.210 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2003 | 9 | 0.210 |
Why?
|
| Actinomycosis | 1 | 2023 | 8 | 0.210 |
Why?
|
| Empyema | 1 | 2023 | 24 | 0.210 |
Why?
|
| Hysterotomy | 1 | 2024 | 135 | 0.210 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2023 | 29 | 0.200 |
Why?
|
| Laparotomy | 1 | 2024 | 143 | 0.200 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2003 | 22 | 0.200 |
Why?
|
| Diagnostic Imaging | 2 | 2022 | 278 | 0.200 |
Why?
|
| Globus Pallidus | 1 | 2003 | 69 | 0.200 |
Why?
|
| Basal Ganglia | 1 | 2003 | 58 | 0.200 |
Why?
|
| Heart Defects, Congenital | 1 | 2015 | 1840 | 0.200 |
Why?
|
| Female | 22 | 2025 | 68037 | 0.200 |
Why?
|
| Surface Plasmon Resonance | 1 | 2022 | 52 | 0.200 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2023 | 63 | 0.200 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2023 | 37 | 0.190 |
Why?
|
| Fourth Ventricle | 1 | 2022 | 8 | 0.190 |
Why?
|
| Survivorship | 1 | 2022 | 46 | 0.180 |
Why?
|
| Tinnitus | 1 | 2022 | 23 | 0.180 |
Why?
|
| Anemia | 1 | 2025 | 330 | 0.180 |
Why?
|
| Cerebellar Ataxia | 1 | 2022 | 68 | 0.180 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2023 | 242 | 0.180 |
Why?
|
| Prognosis | 3 | 2024 | 4697 | 0.180 |
Why?
|
| Dermoid Cyst | 1 | 2021 | 34 | 0.180 |
Why?
|
| Scalp | 1 | 2021 | 55 | 0.180 |
Why?
|
| Meningomyelocele | 1 | 2024 | 249 | 0.180 |
Why?
|
| Male | 21 | 2025 | 62225 | 0.170 |
Why?
|
| Medical Oncology | 1 | 2022 | 230 | 0.170 |
Why?
|
| Proton Therapy | 1 | 2022 | 150 | 0.170 |
Why?
|
| Malignant Atrophic Papulosis | 1 | 2020 | 3 | 0.170 |
Why?
|
| Radiology Department, Hospital | 1 | 2020 | 24 | 0.160 |
Why?
|
| Paranasal Sinuses | 1 | 2020 | 18 | 0.160 |
Why?
|
| Fetoscopy | 1 | 2024 | 456 | 0.160 |
Why?
|
| Head and Neck Neoplasms | 1 | 2025 | 587 | 0.160 |
Why?
|
| Streptococcal Infections | 1 | 2022 | 245 | 0.160 |
Why?
|
| Mitochondrial Diseases | 1 | 2022 | 146 | 0.160 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 266 | 0.160 |
Why?
|
| Hematoma, Subdural | 1 | 2019 | 24 | 0.160 |
Why?
|
| Thrombotic Microangiopathies | 1 | 2020 | 49 | 0.160 |
Why?
|
| Cerebrovascular Disorders | 1 | 2020 | 111 | 0.150 |
Why?
|
| Infant, Newborn | 7 | 2024 | 8381 | 0.150 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2023 | 145 | 0.150 |
Why?
|
| Spinal Injuries | 1 | 2019 | 30 | 0.150 |
Why?
|
| Meningitis, Viral | 1 | 2018 | 10 | 0.150 |
Why?
|
| Branchio-Oto-Renal Syndrome | 1 | 2018 | 11 | 0.150 |
Why?
|
| Central Nervous System Viral Diseases | 1 | 2018 | 12 | 0.150 |
Why?
|
| Temporal Bone | 2 | 2018 | 36 | 0.150 |
Why?
|
| Myelitis | 1 | 2018 | 14 | 0.150 |
Why?
|
| Neuromuscular Diseases | 1 | 2018 | 48 | 0.140 |
Why?
|
| Cochlea | 1 | 2018 | 88 | 0.140 |
Why?
|
| Polyneuropathies | 1 | 2018 | 30 | 0.140 |
Why?
|
| Ipilimumab | 1 | 2018 | 58 | 0.140 |
Why?
|
| West Nile virus | 1 | 2018 | 116 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 282 | 0.130 |
Why?
|
| Child Abuse | 1 | 2019 | 198 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2018 | 361 | 0.130 |
Why?
|
| West Nile Fever | 1 | 2018 | 138 | 0.130 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 121 | 0.120 |
Why?
|
| Pregnancy | 3 | 2024 | 7395 | 0.120 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2016 | 12 | 0.120 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 391 | 0.120 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 642 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 359 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 372 | 0.110 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2014 | 9 | 0.110 |
Why?
|
| Transverse Sinuses | 1 | 2014 | 1 | 0.110 |
Why?
|
| Lateral Sinus Thrombosis | 1 | 2014 | 3 | 0.110 |
Why?
|
| Adolescent | 8 | 2025 | 19986 | 0.110 |
Why?
|
| Hearing Aids | 1 | 2014 | 31 | 0.110 |
Why?
|
| Vertebral Artery | 1 | 2014 | 18 | 0.110 |
Why?
|
| Optic Nerve Diseases | 1 | 2014 | 52 | 0.110 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2014 | 79 | 0.100 |
Why?
|
| Glasgow Coma Scale | 1 | 2014 | 194 | 0.100 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 2013 | 6 | 0.100 |
Why?
|
| Accidents, Traffic | 1 | 2014 | 103 | 0.100 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 627 | 0.100 |
Why?
|
| Neck | 1 | 2014 | 141 | 0.100 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2013 | 48 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1125 | 0.100 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2013 | 157 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 380 | 0.090 |
Why?
|
| Audiometry | 1 | 2011 | 22 | 0.090 |
Why?
|
| Sampling Studies | 1 | 2011 | 73 | 0.090 |
Why?
|
| Ataxia | 2 | 2022 | 159 | 0.090 |
Why?
|
| Melanoma | 1 | 2018 | 927 | 0.080 |
Why?
|
| Cochlear Implantation | 1 | 2011 | 53 | 0.080 |
Why?
|
| Risk Factors | 2 | 2015 | 10374 | 0.080 |
Why?
|
| Survivors | 2 | 2022 | 344 | 0.080 |
Why?
|
| Rare Diseases | 1 | 2011 | 198 | 0.080 |
Why?
|
| Organometallic Compounds | 2 | 2013 | 109 | 0.070 |
Why?
|
| Cytokines | 1 | 2015 | 1317 | 0.070 |
Why?
|
| Syndrome | 1 | 2011 | 1114 | 0.070 |
Why?
|
| United States | 5 | 2021 | 11187 | 0.070 |
Why?
|
| Electroencephalography | 1 | 2011 | 845 | 0.060 |
Why?
|
| Gray Matter | 1 | 2025 | 44 | 0.060 |
Why?
|
| Biomarkers | 1 | 2015 | 3149 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2015 | 6178 | 0.050 |
Why?
|
| Meninges | 1 | 2023 | 20 | 0.050 |
Why?
|
| Heterocyclic Compounds | 1 | 2003 | 17 | 0.050 |
Why?
|
| Glutaryl-CoA Dehydrogenase | 1 | 2003 | 4 | 0.050 |
Why?
|
| Gadolinium DTPA | 1 | 2003 | 47 | 0.050 |
Why?
|
| Joint Diseases | 1 | 2003 | 32 | 0.050 |
Why?
|
| Spin Labels | 1 | 2023 | 21 | 0.050 |
Why?
|
| Hashimoto Disease | 1 | 2023 | 26 | 0.050 |
Why?
|
| Streptococcus gallolyticus | 1 | 2022 | 3 | 0.050 |
Why?
|
| Gadolinium | 1 | 2003 | 108 | 0.050 |
Why?
|
| Verbal Learning | 1 | 2022 | 69 | 0.050 |
Why?
|
| Streptococcus | 1 | 2022 | 61 | 0.050 |
Why?
|
| Intelligence Tests | 1 | 2022 | 59 | 0.050 |
Why?
|
| Protons | 1 | 2022 | 98 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2023 | 130 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2023 | 244 | 0.050 |
Why?
|
| Encephalitis | 1 | 2023 | 117 | 0.050 |
Why?
|
| Penicillins | 1 | 2022 | 155 | 0.050 |
Why?
|
| Organizational Objectives | 1 | 2020 | 31 | 0.040 |
Why?
|
| Gestational Age | 1 | 2024 | 1206 | 0.040 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2020 | 61 | 0.040 |
Why?
|
| Biological Factors | 1 | 2020 | 26 | 0.040 |
Why?
|
| Cranial Nerve Diseases | 1 | 2020 | 23 | 0.040 |
Why?
|
| Personal Protective Equipment | 1 | 2020 | 52 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2003 | 370 | 0.040 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2020 | 45 | 0.040 |
Why?
|
| Urinary Incontinence | 1 | 2020 | 72 | 0.040 |
Why?
|
| Workplace | 1 | 2020 | 74 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 411 | 0.040 |
Why?
|
| Headache | 1 | 2020 | 97 | 0.040 |
Why?
|
| Nitriles | 1 | 2020 | 149 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2020 | 355 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 950 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 2038 | 0.040 |
Why?
|
| Cerebellum | 1 | 2022 | 415 | 0.040 |
Why?
|
| 14-3-3 Proteins | 1 | 2018 | 56 | 0.040 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2018 | 89 | 0.040 |
Why?
|
| Adult | 4 | 2023 | 30314 | 0.040 |
Why?
|
| Cerebral Aqueduct | 1 | 2018 | 11 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2020 | 272 | 0.040 |
Why?
|
| Family | 1 | 2021 | 576 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 1019 | 0.030 |
Why?
|
| Herpesvirus 4, Human | 1 | 2020 | 615 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2020 | 327 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2018 | 248 | 0.030 |
Why?
|
| Skin | 1 | 2020 | 516 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2020 | 405 | 0.030 |
Why?
|
| Cognition | 1 | 2022 | 782 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 1146 | 0.030 |
Why?
|
| Mitochondria | 1 | 2022 | 722 | 0.030 |
Why?
|
| Meningeal Neoplasms | 1 | 2018 | 167 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2020 | 566 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 5107 | 0.030 |
Why?
|
| Suture Anchors | 1 | 2014 | 1 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2024 | 12393 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2025 | 3260 | 0.030 |
Why?
|
| Optic Disk | 1 | 2014 | 31 | 0.030 |
Why?
|
| Fetus | 1 | 2018 | 578 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2014 | 231 | 0.030 |
Why?
|
| Texas | 1 | 2022 | 3536 | 0.030 |
Why?
|
| Disease Progression | 1 | 2020 | 2110 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2014 | 223 | 0.030 |
Why?
|
| Observer Variation | 1 | 2014 | 306 | 0.030 |
Why?
|
| Meglumine | 1 | 2013 | 16 | 0.030 |
Why?
|
| Optic Nerve | 1 | 2014 | 87 | 0.030 |
Why?
|
| Subtraction Technique | 1 | 2013 | 36 | 0.030 |
Why?
|
| Random Allocation | 1 | 2013 | 420 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 2014 | 596 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 4894 | 0.020 |
Why?
|
| Prevalence | 1 | 2014 | 2571 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 2877 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 2176 | 0.020 |
Why?
|
| Middle Aged | 2 | 2020 | 27402 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2014 | 3307 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6582 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 20078 | 0.010 |
Why?
|